该项收购完成后,Cambrex公司将获得Avista公司包括从原料药、药品开发、环化核苷酸制造,到独立分析、微生物测验以及固态科学等多项服务,同时将Avista的4个制药站点纳入其生...查看全文
琬麟2015-02-07 09:21
$凯姆布雷克斯(CBM)$ EAST RUTHERFORD, N.J., Feb. 6, 2015 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM, "Cambrex") is pleased to announce that it has initiated the second significant expansion of its Charles City, Iowa facility in less than three years. Strong continu...查看全文
$凯姆布雷克斯(CBM)$ 内部交易: 2017-10-02,总裁 & CEO,KLOSK STEVEN M ,卖出,4000普通股, $54.96
$凯姆布雷克斯(CBM)$ 内部交易: 2017-10-02,总裁 & CEO,KLOSK STEVEN M ,期权,4000普通股, $5.72
$凯姆布雷克斯(CBM)$ 10-Q - Quarterly report [Sections 13 or 15(d)]: v Filed: 2017-08-04 AccNo: 0001437749-17-013739 Size: 4 MB 网页链接
$凯姆布雷克斯(CBM)$ 8-K - Current report: i Filed: 2017-08-04 AccNo: 0001437749-17-013737 Size: 368 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$凯姆布雷克斯(CBM)$ 10-Q - Quarterly report [Sections 13 or 15(d)]: v Filed: 2017-08-04 AccNo: 0001437749-17-013739 Size: 4 MB 网页链接
$凯姆布雷克斯(CBM)$ 8-K - Current report: i Filed: 2017-08-04 AccNo: 0001437749-17-013737 Size: 368 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$凯姆布雷克斯(CBM)$ 美东时间 2017-08-04 盘前 披露财报,预期EPS 0.75 网页链接
$凯姆布雷克斯(CBM)$ 内部交易: 2017-07-03,总裁 & CEO,KLOSK STEVEN M ,卖出,12000普通股, $59.66
$凯姆布雷克斯(CBM)$ 内部交易: 2017-07-03,总裁 & CEO,KLOSK STEVEN M ,期权,12000普通股, $5.72
$凯姆布雷克斯(CBM)$ 内部交易: 2017-06-12,VP, General Counsel,Hanley Samantha ,卖出,14000普通股, $57.56